FDA Office of Prescription Drug Promotion (OPDP) · United States

FDA OPDP Boxed Warning Marketing Standards

Promotion of drugs with a boxed warning must convey the boxed-warning risk with prominence comparable to benefit claims, and reminder ads are not permitted for these drugs.

21 CFR 202.1(e)(1), (e)(2)(i), (e)(5)(ii), (e)(7)(viii); 21 CFR 201.57(c)(1); 21 U.S.C. 352(n)

What is FDA OPDP Boxed Warning Marketing Standards?

Promotion of drugs with a boxed warning must convey the boxed-warning risk with prominence comparable to benefit claims, and reminder ads are not permitted for these drugs. Consumer and HCP promotion for prescription drugs whose labeling carries a boxed warning.

US Federal

Read official source

Last reviewed: 2026-11-05

General information, not legal advice.

Who does this rule apply to?

general_audience, general_adults_18plus, customers, patients, health_professionals · Prescription Drug · pharma

Where does this rule apply?

United States

Which marketing channels are covered?

all_channels

When does this rule take effect?

2026-11-06

What does this rule require?

Promotion of drugs with a boxed warning must convey the boxed-warning risk with prominence comparable to benefit claims, and reminder ads are not permitted for these drugs.

How can marketing teams comply?

Consumer and HCP promotion for prescription drugs whose labeling carries a boxed warning.

Where can I read the official source?

Read official source

Key facts

Regulatory authority
FDA Office of Prescription Drug Promotion (OPDP)
Jurisdiction
United States
Official citation
21 CFR 202.1(e)(1), (e)(2)(i), (e)(5)(ii), (e)(7)(viii); 21 CFR 201.57(c)(1); 21 U.S.C. 352(n)
Published
2026-11-16
Effective date
2026-11-06
Channel
all_channels
Products
Prescription Drug
Audiences
general_audience, general_adults_18plus, customers, patients, health_professionals

Frequently asked questions

What is FDA OPDP Boxed Warning Marketing Standards?

Promotion of drugs with a boxed warning must convey the boxed-warning risk with prominence comparable to benefit claims, and reminder ads are not permitted for these drugs.

Who does this rule apply to?

general_audience, general_adults_18plus, customers, patients, health_professionals · Prescription Drug · pharma

Where does this rule apply?

United States

Which marketing channels are covered?

all_channels

When does this rule take effect?

2026-11-06

Request a free compliance scan of your homepage and book a time with Warrant.

Get a free homepage compliance scan